1
|
Cancer Information Service, National
Cancer Center, Japan (National Cancer Registry, Ministry of Health,
Labour and Welfare): Cancer Statistics. https://ganjoho.jp/public/qa_links/report/statistics/en.html.
Accessed May 14, 2024.
|
2
|
Baumann R, Depping R, Delaperriere M and
Dunst J: Targeting hypoxia to overcome radiation resistance in head
& neck cancers: Real challenge or clinical fairytale? Expert
Rev Anticancer Ther. 16:751–758. 2016.PubMed/NCBI View Article : Google Scholar
|
3
|
American Cancer Society: Colorectal Cancer
Facts & Figures 2020-2022. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2020-2022.pdf.
Accessed May 14, 2024.
|
4
|
World Health Organization, International
Agency for Research on Cancer (IARC): Global Cancer Observator, CBP
Survmark-2. https://gco.iarc.who.int/survival/survmark/visualizations/viz2/?cancer_site=%22Rectum%22&country=%22Australia%22&agegroup=%22All%22&gender=%22All%22&interval=%221%22&survival_year=%221%22&measures=%5B%22Incidence+%28ASR%29%22%2C%22Mortality+%28ASR%29%22%2C%22Net+Survival%22%5D.
Accessed May 14, 2024.
|
5
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691.
2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Swedish Rectal Cancer Trial. Cedermark B,
Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE and Wilking N:
Improved survival with preoperative radiotherapy in resectable
rectal cancer. N Engl J Med. 336:980–987. 1997.PubMed/NCBI View Article : Google Scholar
|
8
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
et al: Preoperative versus postoperative chemoradiotherapy for
rectal cancer. N Engl J Med. 351:1731–1740. 2004.PubMed/NCBI View Article : Google Scholar
|
9
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase Ⅲ trial after a median follow-up of
11 years. J Clin Oncol. 30:1926–1933. 2012.PubMed/NCBI View Article : Google Scholar
|
10
|
Benson AB, Venook AP, Al-Hawary MM, Azad
N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Garrido-Laguna I, et al: Rectal Cancer, Version 2.2022, NCCN
Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw.
20:1139–1167. 2022.PubMed/NCBI View Article : Google Scholar
|
11
|
Tang L, Wei F, Wu Y, He Y, Shi L, Xiong F,
Gong Z, Guo C, Li X, Deng H, et al: Role of metabolism in cancer
cell radioresistance and radiosensitization methods. J Exp Clin
Canc Res. 37(87)2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Wang H, Jiang H, Van De Gucht M and De
Ridder M: Hypoxic radioresistance: Can ROS be the key to overcome
it? Cancers (Basel). 11(112)2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Kariya S, Sawada K, Kobayashi T, Karashima
T, Shiuin T, Nishioka A and Ogawa Y: Combination treatment of
hydrogen peroxide and X-rays induces apoptosis in human prostate
cancer PC-3 cells. Int J Radiat Oncol Biol Phys. 75:449–454.
2009.PubMed/NCBI View Article : Google Scholar
|
14
|
Ogawa Y, Kubota K, Ue H, Kataoka Y,
Tadokoro M, Miyatake K, Tsuzuki K, Yamanashi T, Itoh S, Hitomi J,
et al: Phase I study of a new radiosensitizer containing hydrogen
peroxide and sodium hyaluronate for topical tumor injection: A new
enzyme-targeting radiosensitization treatment, Kochi
Oxydol-Radiation Therapy for Unresectable Carcinomas, type II
(KORTUC II). Int J Oncol. 34:609–618. 2009.PubMed/NCBI View Article : Google Scholar
|
15
|
Aoyama N, Ogawa Y, Yasuoka M, Ohgi K,
Iwasa H, Miyatake K, Yoshimatsu R, Yamanishi T, Hamada N, Tamura T,
et al: Therapeutic results of a novel enzyme-targeting
radiosensitization treatment, Kochi oxydol-radiation therapy for
unresectable carcinomas II, in patients with stage I primary breast
cancer. Oncol Lett. 13:4741–4747. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
Nishioka A, Ogawa Y, Miyatake K, Tadokoro
M, Nogami M, Hamada N, Kubota K, Kariya S, Kohsaki T, Saibara T, et
al: Safety and efficacy of image-guided enzyme-targeting
radiosensitization and intraoperative radiotherapy for locally
advanced unresectable pancreatic cancer. Oncol Lett. 8:404–408.
2014.PubMed/NCBI View Article : Google Scholar
|
17
|
Hu R, Saito AI, Mitsuhashi T, Inoue T,
Ohta T, Ujihira T, Yoshida K and Sasai K: Radiosensitization using
hydrogen peroxide in patients with cervical cancer. Mol Clin Oncol.
15(142)2021.PubMed/NCBI View Article : Google Scholar
|
18
|
National Cancer Institute: Common
Terminology Criteria for Adverse Events (CTCAE). Version 4.0.
https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc.
Accessed May 14, 2024.
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
20
|
Saito AI, Hirai T, Inoue T, Hojo N, Kawai
S, Kato Y, Ito K, Kato M, Ozawa Y, Shinjo H, et al: Time to pain
relapse after palliative radiotherapy for bone metastasis: A
prospective multi-institutional study. Anticancer Res. 43:865–873.
2023.PubMed/NCBI View Article : Google Scholar
|
21
|
Miyatake K, Kubota K, Ogawa Y, Hamada N,
Murata Y and Nishioka A: Nonsurgical care for locally advanced
breast cancer: Radiologically assessed therapeutic outcome of a new
enzyme-targeting radiosensitization treatment, Kochi
Oxydol-Radiation Therapy for Unresectable Carcinomas, type II
(KORTUC II) with systemic chemotherapy. Oncol Rep. 24:1161–1168.
2010.PubMed/NCBI View Article : Google Scholar
|
22
|
Aoyama N, Ogawa Y, Yasuoka M, Takahashi M,
Iwasa H, Miyatake K, Yamanishi T, Hamada N, Tamura T, Nishioka A
and Yamagami T: Therapeutic response to a novel enzyme-targeting
radiosensitization treatment (Kochi Oxydol-Radiation Therapy for
Unresectable Carcinomas) in patients with recurrent breast cancer.
Oncol Lett. 12:29–34. 2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Ogawa Y, Kubota K, Ue H, Tadokoro M,
Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
et al: Safety and effectiveness of a new enzyme targeting
radiosensitization treatment (KORTUC II) for intratumoral injection
for low LET radioresistant tumors. Int J Oncol. 39:553–560.
2011.PubMed/NCBI View Article : Google Scholar
|
24
|
Aoyama N, Ogawa Y, Yasuoka M, Iwasa H,
Miyatake K, Yoshimatsu R, Yamanishi T, Hamada N, Tamura T,
Kobayashi K, et al: Therapeutic response to a novel
enzyme-targeting radiosensitization treatment (KORTUC II) for
residual lesions in patients with stage IV primary breast cancer,
following induction chemotherapy with epirubicin and
cyclophosphamide or taxane. Oncol Lett. 13:69–76. 2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Hitomi J, Kubota K, Ogawa Y, Hamada N,
Murata Y and Nishioka A: Non-surgical therapy and radiologic
assessment of stage I breast cancer treatment with novel
enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy
for Unresectable Carcinomas, type II (KORTUC II). Exp Ther Med.
1:769–775. 2010.PubMed/NCBI View Article : Google Scholar
|
26
|
Ito Y, Ohtsu A, Ishikura S, Boku N, Nihei
K, Ogino T and Ikeda H: Efficacy of chemoradiotherapy on pain
relief in patients with intrapelvic recurrence of rectal cancer.
Jpn J Clin Oncol. 33:180–185. 2003.PubMed/NCBI View Article : Google Scholar
|
27
|
Guren MG, Undseth C, Rekstad BL,
Brændengen M, Dueland S, Spindler KL, Glynne-Jones R and Tveit KM:
Reirradiation of locally recurrent rectal cancer: A systematic
review. Radiother Oncol. 113:151–157. 2014.PubMed/NCBI View Article : Google Scholar
|
28
|
Lee J, Kim CY, Koom WS and Rim CH:
Practical effectiveness of re-irradiation with or without surgery
for locoregional recurrence of recta cancer: A meta-analysis and
systematic review. Radiother Oncol. 140:10–19. 2019.PubMed/NCBI View Article : Google Scholar
|